VSTM — Verastem, Inc.

VSTMVerastem, Inc.

NAS · US · Healthcare · Biotechnology · verastem.com

4.340USD+2.36%Mkt Cap: 384.89M USDP/E: —Last update: 2026-05-26

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap384.89M USD

Enterprise Value279.02M USD

Revenue (TTM)49.59M USD

Gross Profit25.62M USD

Net Income (TTM)-209.47M USD

Revenue/Share0.6170 USD

Last Price4.340 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees102

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-3.59

PEG—

EV/EBITDA-1.64

EV/Revenue5.63

P/S7.57

P/B5.80

EPS (TTM)-2.52

EPS (Forward)-1.19

52W Range

4.0005% of range11.25

52W High11.25 USD

52W Low4.000 USD

Profitability

Gross Margin82.86%

Oper. Margin-240.46%

EBITDA Margin0.00%

Profit Margin-677.59%

ROE-366.23%

ROA-85.00%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-137.51M USD

CapEx (TTM)9.62M USD

FCF Margin-186.91%

FCF Yield-24.08%

Net Debt-96.20M USD

Net Debt/EBITDA0.57

Balance Sheet

Debt/Equity1.52

Current Ratio3.04

Quick Ratio2.87

Book Value/Sh0.7360 USD

Cash/Share2.067 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:12

Split DateJun 1, 2023

Analyst Consensus

Rating1.1 (Strong Buy)

Target (Mean)16.00 USD

Target Range14.00 USD – 18.00 USD

# Analysts8

Ownership

Shares Out.87.87M

Float70.44M

Insiders0.67%

Institutions93.51%

Short Interest

Short Ratio8.4d

Short % Float20.07%

Short % Out.19.95%

Shares Short17.52M

Short (prev mo.)16.37M

Technical

SMA 505.445 (-20.3%)

SMA 2007.433 (-41.6%)

Beta0.34

S&P 52W Chg28.31%

Avg Vol (30d)2.26M

Avg Vol (10d)2.72M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—